measuring system could not be employed, the absolute efficiency
values are not directly comparable with the other published
results. However, the reported efficiencies and the relative effi-
ciency changes are comparable within the presented devices.
(49.05 mg, 0.16 mmol), sodium tert-butoxide (191.17 mg, 2
mmol) and pyrrolidine (0.16 mL, 2 mmol). The reaction
temperature was adjusted to 80 ꢀC and the reaction completed in
30 minutes. The procedure gave the title compound 3b as yellow
crystals (0.38 g, 80%). Mp 102–103 ꢀC. 1H NMR (200 MHz;
DMSO-d6; Me4Si) 1.90 (4H, br s), 3.14 (4H, br s), 5.23 (2H, s,
CH2), 6.93 (1H, d, J ¼ 8.3), 7.10 (1H, d, J ¼ 8.7), 7.32–7.54 (6H,
m), 8.47 (1H, d, J ¼ 8.7), 8.83 (1H, d, J ¼ 2.6). 13C NMR (50
MHz; DMSO-d6; Me4Si) 24.9 (2C), 53.4 (2C), 71.1 (CH2), 111.5,
112.9, 121.2, 124.8, 128.6 (3C), 129.2 (2C), 133.5, 138.4, 141.5,
141.6, 149.5, 150.0. HRMS: calcd for C20H21N2O ([M + H]+)
305.1654, found 305.1659.
3.7 General considerations about syntheses
All reactions were carried out under argon atmosphere except the
palladium catalyzed deprotection of the benzyloxy group in 8-
(benzyloxy)-5-bromoquinoline 2 which was carried out under
hydrogen atmosphere. Solvents were dried by molecular sieves of
the proper size. 5-Bromo-8-hydroxyquinoline was purchased
from Tokyo Chemical Industry Co. (TCI). 8-(Benzyloxy)-5-
bromoquinoline was synthesized according to previously pub-
lished procedures.11 Ligands (L1–L3) were purchased from
Aldrich Chemical company. Palladium acetate was purchased
from Fluka Chemical Company. Melting points were determined
using a METTLER TOLEDO DSC821 at a heating rate of 10 ꢀC
minꢁ1. NMR analyses (1H and 13C) were performed using
Bruker DPX 200 (200 MHz) and Varian Mercury 300 MHz
(Varian Inc.) spectrometers. TLC was performed on dry silica gel
plates using a chloroform–methanol mixture as the eluent.
8-(Benzyloxy)-5-morpholin-1-yl)quinoline (3c). The title
compound was prepared by following the general procedure. The
specific amounts of chemicals used: compound 2 (500 mg, 1.59
mmol), Pd(OAc)2 (5 mol%, 17.86 mg, 0.080 mmol), ligand L3
(49.05 mg, 0.16 mmol), sodium tert-butoxide (191.17 mg, 2
mmol) and morpholine (0.17 mL, 2 mmol). The reaction
temperature was adjusted to 100 ꢀC and the reaction time was 3
hours. The procedure gave the title compound 3c as yellowish
crystals (0.43 g, 84%). Mp 119–120 ꢀC. 1H NMR (200 MHz;
DMSO-d6; Me4Si) 2.53 (4H, t, J ¼ 4.2), 3.83 (4H, t, J ¼ 3.9), 5.29
(2H, s, CH2), 7.17–7.24 (2H, m), 7.36–7.61 (6H, m), 8.53 (1H, dd,
J ¼ 8.8, 1.7), 8.88 (1H, dd, J ¼ 4.1, 1.5). 13C NMR (50 MHz;
DMSO-d6; Me4Si) 53.9 (2C), 67.0 (2C), 70.5, 110.1, 115.9, 121.7,
124.8, 128.2 (3C), 128.9 (2C), 132.1, 137.7, 141.2, 142.6, 149.4,
151.1. HRMS: calcd for C20H21N2O2 ([M + H]+) 321.1603,
found 321.1571.
3.8 General procedure for the synthesis of 8-(benzyloxy)-5-
aminoquinoline derivatives 3(a–c) via Hartwig–Buchwald
amination reaction
In an oven dried vessel with a magnetic stirring bar, toluene was
added and bubbled with argon for 10 min. Compound 2,
Pd(OAc)2 (5 mol%), ligand of choice after optimization (10 mol
%), sodium tert-butoxide (1.25 equiv.) and amine (1.25 equiv.)
were added and the reaction mixture stirred under argon at
appropriate temperature. The reaction mixture was then allowed
to cool to room temperature, filtered through a thin pad of silica
gel and the solvent was evaporated under vacuum. The product
was purified by flash chromatography using acetone–n-hexane
(1 : 1) as the eluent.
3.9 General procedure for the synthesis of 5-amino-8-
hydroxyquinolines 4(a–c)
In a dry two-necked round bottom flask, 150 mg of 5-amino-8-
benzyloxyquinoline (3a–c) and 30 mg Pd–C (10 wt%) were stirred
and refluxed in ethanol under hydrogen atmosphere for 3 hours.
The reaction mixture was then filtered through a thin pad of silica
gel. The solvent was evaporated under vacuum and the residue
was recrystallized from the appropriate solvent.
8-(Benzyloxy)-5-(piperidin-1-yl)quinoline (3a). The title
compound was prepared by following the general procedure. The
specific amounts of chemicals used: compound 2 (250 mg, 0.796
mmol), Pd(OAc)2 (9.0 mg, 0.040 mmol), ligand L2 (24.3 mg,
0.080 mmol), sodium tert-butoxide (96.8 mg, 1.01 mmol) and
piperidine (0.10 mL, 1.01 mmol). The reaction was stirred for
24 h at 100 ꢀC. The procedure gave the title compound 3a as an
off-white powder (213 mg, 84%). Mp 113–114 ꢀC. 1H NMR (300
MHz; DMSO-d6; Me4Si) 1.59 (2H, br s), 1.75 (4H, q, J ¼ 5.4),
2.89 (4H, br s), 5.26 (2H, s), 7.09 (1H, d, J ¼ 8.1), 7.18 (1H, d, J ¼
8.4), 7.32–7.45 (3H, m), 7.52–7.58 (3H, m), 8.46 (1H, dd, J ¼ 8.6,
1.7), 8.85 (1H, dd, J ¼ 4.0, 1.6). 13C NMR (75 MHz; DMSO-d6;
Me4Si) 24.0 (CH2), 26.2 (2C, CH2), 54.4 (2C, CH2), 70.1 (CH2),
110.0, 115.1, 121.1, 124.6, 127.8 (3C), 128.4 (2C), 131.7, 137.3,
140.7, 143.6, 148.8, 150.2. HRMS: calcd for C21H23N2O ([M +
H]+) 319.1810, found 319.1822.
5-Piperidinyl-8-hydroxyquinoline (4a). Compound 4a was
prepared according to the general procedure, dissolved in
ethanol, filtered through a 0.20 mm syringe filter and the filtrate
was evaporated to dryness. The precipitate was boiled in water,
cooled to rt, filtered and washed with water. These procedures
gave the product as a greenish powder (102 mg, 94%). Mp 115–
116 ꢀC. 1H NMR (300 MHz; DMSO-d6; Me4Si) 1.58 (2H, br s),
1.74 (4H, q, J ¼ 5.4), 2.88 (4H, br s), 6.98 (1H, d, J ¼ 8.1), 7.07
(1H, d, J ¼ 8.1), 7.56 (1H, dd, J ¼ 8.6, 4.2), 8.46 (1H, dd, J ¼ 8.6,
1.4), 8.83 (1H, dd, J ¼ 4.0, 1.2), 9.38 (1H, br s). 13C NMR (75
MHz; DMSO-d6; Me4Si) 24.0 (CH2), 26.2 (2C, CH2), 54.5 (2C,
CH2), 110.4, 116.2, 121.1, 124.2, 132.0, 139.1, 141.9, 147.9, 149.1.
HRMS: calcd for C14H17N2O ([M + H]+) 229.1341, found
229.1348.
8-(Benzyloxy)-5-(pyrrolidin-1-yl)quinoline (3b). The title
compound was prepared by following the general procedure. The
specific amounts of chemicals used: compound 2 (500 mg, 1.59
mmol), Pd(OAc)2 (5 mol%, 17.86 mg, 0.080 mmol), ligand L3
5-Pyrrolidinyl-8-hydroxyquinoline (4b). Compound 4b was
prepared according to the general procedure and recrystallized
from methanol to give yellow crystals (72 mg, 68%). Mp 83–84
ꢀC. 1H NMR (200 MHz; DMSO-d6; Me4Si) 1.92 (4H, br s),
22980 | J. Mater. Chem., 2012, 22, 22971–22982
This journal is ª The Royal Society of Chemistry 2012